Zurueck zur Suche

Reporte zur Charge UT7411JA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 VA 1 NJ 1 OH 1 IN 1

VAERS 2453686

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7411JA

schwer
Staat
MI
Alter
43,0
Geschlecht
M
Eingang
21.09.2022
Impfdatum
17.11.2021
Beginn
17.09.2022
Tage bis Beginn
304,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain lower Anion gap Blood bicarbonate decreased Blood pH decreased COVID-19 Condition aggravated Cough Diabetic ketoacidosis Dyspnoea Hyperglycaemia Intensive care Oropharyngeal pain SARS-CoV-2 test positive Vomiting

Symptomtext

Discharge Provider: MD Primary Care Provider: FNP Admission Date: 9/17/2022 Discharge Date: Sep 18, 2022 PRESENTING PROBLEM: DKA, type 2, not at goal (HCC) [E11.10] Diabetic ketoacidosis without coma associated with type 2 diabetes mellitus (HCC) [E11.10] Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin (HCC) [E11.65, Z79.4] Left lower quadrant abdominal pain [R10.32] COVID-19 [U07.1] HOSPITAL COURSE: 44 year old male with history of insulin dependant DMII who presented to ER on 9/17/22 with complaints of vomiting. On 9/16/22, patient started with sore throat, cough and SOB. Shortly after, he started with vomiting. Initially, blood sugars were controlled but then started to trend upward despite insulin use. He continued with vomiting overnight and ultimately presented to the ER on 9/17/22. He was found to be in DKA with pH 7.3, anion gap of 25 and bicarb of 12. He was admitted to the ICU, given IV fluids and started on insulin drip. By morning of 9/18/22, anion gap closed and patient was tolerating diet. Blood sugars remained stable on basal bolus insulin and patient is discharged home. Patient did test positive for COVID on 9/18/22. He did have brief time when oxygen saturations decreased to 88% on room air. He was placed on 2L oxygen but was able to quickly wean back to room air. With drop in oxygen saturations, he was started on oral decardon and IV Remdesivir. By discharge, symptoms are mild and he remains on room air. He was instructed to follow CDC guidelines and remain in isolation for 5 days at home. No medications prescribed at discharge. He can treat symptoms with OTC meds prn.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
11/8/2021 - 11/10/2021 (2 days) HOSPITAL PRESENTING PROBLEM: DKA, type 2, not at goal (HCC) [E11.10] Left upper quadrant abdominal pain [R10.12] Ketoacidosis in type 2 diabetes mellitus without coma (HCC) [E11.10]
Vorgeschichte
Femoroacetabular impingement of right hip Allergic rhinitis Chronic tension-type headache, not intractable Essential tremor Essential hypertension Irritable colon Long term (current) use of insulin (HCC) Major depressive disorder, recurrent, moderate (HCC) Migraine without aura and without status migrainosus, not intractable Mixed hyperlipidemia PTSD (post-traumatic stress disorder) Tobacco abuse Type 2 diabetes mellitus with complication, with long-term current use of insulin (HCC) Kidney stone Aftercare following surgery of the musculoskeletal system Metabolic acidosis due to diabetes mellitus (HCC) GERD (gastroesophageal reflux disease) COVID-19
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet aspirin 81 MG enteric coated tablet atorvastatin (LIPITOR) 20 MG tablet cyclobenzaprine (FLEXERIL) 10 MG tablet dulaglutide (TRULICITY) 1.5 MG/0.5ML injection fluticasone (FLONASE) 50 MCG/ACT nasal spra
Allergien
MetforminRash
Vorherige Impfungen
-

VAERS 1849148

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7411JA

schwer
Staat
VA
Alter
1,0
Geschlecht
F
Eingang
06.11.2021
Impfdatum
04.11.2021
Beginn
06.11.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Febrile convulsion Irritability Lethargy Pyrexia

Symptomtext

Symptoms were fussy, lethargic and low grade fever for 24 hours, then lethargy for 2nd 24 hours and mid level fever, then febrile seizure at hour 50 post vaccines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2450441

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7411JA

gering
Staat
NJ
Alter
80,0
Geschlecht
F
Eingang
17.09.2022
Impfdatum
08.09.2022
Beginn
08.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

have received an expired FLUZONE QIV vaccine with no reported adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid non-serious case received from a consumer/non-HCP (Healthcare professional). This case is linked to case 2022SA375602(CLUSTER). This case involves a 80 years old female patient who received an expired Influenza quadrival A-B vaccine [Fluzone QIV] vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 08-Sep-2022, the patient received first dose, 0.5 ml of suspect Influenza quadrival A-B vaccine, pre-filled syringes (lot UT7411JA 30-Jun-2022) via intramuscular route in the deltoid NOS (not otherwise specified) as Immunization. On 08-Sep-2022 (latency: same day), the patient has received an expired Fluzone QIV vaccine with no reported adverse event (expired product administered). One of the boxes of Fluzone QIV NP pre-filled syringes that was received on 01-Sep-2022 contained multiple lot numbers and that up to 10 pre-filled syringes had already expired on 30-Jun-2022. Also, as many as 6 other patients may have received expired Fluzone QIV NP vaccines earlier in the week. Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2325546

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7411JA

gering
Staat
MI
Alter
30,0
Geschlecht
F
Eingang
21.06.2022
Impfdatum
15.06.2022
Beginn
15.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Flu vaccine given in place of HPV vaccine, no adverse events, patient notified.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
No adverse event.
Aktuelle Erkrankungen
NA
Vorgeschichte
-
Andere Medikamente
Depo-Provera 150mg
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1955334

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7411JA

gering
Staat
OH
Alter
0,2
Geschlecht
M
Eingang
16.12.2021
Impfdatum
16.12.2021
Beginn
16.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient was not old enough to receive the flu shot and was given by mistake. Patients physician spoke with parents and assured them no harm would come from vaccination. No treatment at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Similac Sensitive
Allergien
None
Vorherige Impfungen
-

VAERS 1947214

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7411JA

gering
Staat
IN
Alter
11,0
Geschlecht
M
Eingang
14.12.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error Needle issue

Symptomtext

child another dose that day with no reported adverse event; twisted the needle onto the syringe and when administering the injection about half the vaccine came out around the luer lock no reported adverse event; Initial information was regarding an unsolicited valid non serious case was received from an other health professional via Agency (Reference number- 00883700) and transmitted to Sanofi on 03-Dec-2021. This case involves an 11-years-old male patient who received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV], child another dose that day (extra dose administered) and twisted the needle onto the syringe and when administering the injection about half the vaccine came out around the luer lock (needle issue). The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included COVID-19 VACCINE (PFIZER BIONTECH) for Immunisation. On 30-Nov-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UT7411JA, expiry date: 30-Jun-2022) via intramuscular route in the left arm for prophylactic vaccination. It was an actual medication error due to extra dose administered and needle issue. (latency: same day). At time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-